Financial Analysis: Alignment Healthcare Inc (ALHC)’s Ratios Unveil Key Insights

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $11.47, up 3.15% from its previous closing price of $11.12. In other words, the price has increased by $3.15 from its previous closing price. On the day, 0.78 million shares were traded. ALHC stock price reached its highest trading level at $11.64 during the session, while it also had its lowest trading level at $11.15.

Ratios:

To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.78 whereas as Long-Term Debt/Eq ratio is at 1.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May 30, 2024, Upgraded its rating to Buy and sets its target price to $11 from $7.75 previously.

On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.

Piper Sandler Upgraded its Neutral to Overweight on May 08, 2024, whereas the target price for the stock was revised from $6 to $8.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Warburg Pincus LLC bought 4,300,000 shares for $11.39 per share.

Maroney Dawn Christine sold 30,000 shares of ALHC for $351,027 on Sep 16 ’24. The President, Markets now owns 1,756,097 shares after completing the transaction at $11.70 per share. On Sep 17 ’24, another insider, KONOWIECKI JOSEPH S, who serves as the Director of the company, sold 16,413 shares for $11.77 each. As a result, the insider received 193,181 and left with 1,141,808 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2194211072 and an Enterprise Value of 2051516416. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98 while its Price-to-Book (P/B) ratio in mrq is 17.73. Its current Enterprise Value per Revenue stands at 0.919 whereas that against EBITDA is -19.623.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $12.36, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 19.46%, while the 200-Day Moving Average is calculated to be 52.79%.

Shares Statistics:

It appears that ALHC traded 1.07M shares on average per day over the past three months and 1379740 shares per day over the past ten days. A total of 188.95M shares are outstanding, with a floating share count of 87.23M. Insiders hold about 54.40% of the company’s shares, while institutions hold 41.07% stake in the company. Shares short for ALHC as of 1726185600 were 4752562 with a Short Ratio of 4.46, compared to 1723680000 on 4653862. Therefore, it implies a Short% of Shares Outstanding of 4752562 and a Short% of Float of 3.88.

Most Popular